10 years of revenue, profit, cash flow and balance-sheet history through FY2016, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2016 | — | $1.2B | — | — | $1.1B | $7.8B | $747M |
| 2015 | — | $1.0B | — | — | $1.0B | $8.0B | $550M |
| 2014 | $5.3B | $1.0B | 94.9% | 42.8% | $930M | $9.1B | $634M |
| 2013 | $5.0B | $1.1B | 95.3% | 45.4% | $1.3B | $7.8B | $683M |
| 2012 | — | $1.2B | — | — | $1.4B | $7.9B | $688M |
| 2011 | — | $1.1B | — | — | $849M | $5.6B | $457M |
| 2010 | — | $979M | — | — | $844M | $4.7B | $523M |
| 2009 | — | $891M | — | — | $765M | $4.6B | $301M |
| 2008 | — | $818M | — | — | $329M | — | $222M |
| 2007 | — | $717M | — | — | $627M | — | $245M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Dec '16 | — | $388M | — | — | $561M | $7.8B | $747M |
| Sep '16 | $4.6B | $333M | 32.0% | 14.6% | $197M | $7.9B | $630M |
| Jun '16 | $4.4B | $294M | 31.6% | 14.5% | -$79M | $8.4B | $723M |
| Mar '16 | $4.2B | $228M | 31.3% | 12.8% | $430M | $8.2B | $518M |
| Dec '15 | — | $317M | — | — | $243M | $8.0B | $550M |
| Sep '15 | $4.2B | $262M | 32.7% | 14.5% | $350M | $8.5B | $621M |
| Jun '15 | $4.2B | $241M | 30.9% | 13.0% | -$234M | $8.9B | $582M |
| Mar '15 | — | $210M | — | — | $648M | $8.7B | $623M |
| Dec '14 | — | $335M | — | — | -$990M | $9.1B | $634M |
| Sep '14 | — | $271M | — | — | $1.8B | $7.9B | $588M |
| Jun '14 | — | $234M | — | — | $230M | $8.6B | $645M |
| Mar '14 | — | $205M | — | — | -$87M | $8.2B | $574M |
| Dec '13 | — | $349M | — | — | $353M | $7.8B | $683M |
| Sep '13 | — | $273M | — | — | $427M | $7.9B | $602M |
| Jun '13 | — | $263M | — | — | $339M | $7.8B | $586M |
| Mar '13 | — | $225M | — | — | $168M | $7.4B | $535M |
| Dec '12 | — | $257M | — | — | $346M | $7.9B | $688M |
| Sep '12 | — | $270M | — | — | $363M | $7.8B | $619M |
| Jun '12 | — | $289M | — | — | $298M | $5.6B | $677M |
| Mar '12 | — | $370M | — | — | $357M | $5.7B | $580M |
How the market has priced FMS against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Fresenius Medical Care Ag's revenue has grown 5.9% per year, and net income grown 3.0% per year. These are computed facts, not advice.
As of FY2016, Fresenius Medical Care Ag reported $7.8B of total debt against $747M of cash; operating income covered interest expense 5.8×.
In FY2016, gross margin was —, operating margin —, and net margin —.
As of Jun '26, Fresenius Medical Care Ag traded at a price-to-earnings ratio of about 5.7× (market cap ÷ latest annual net income). The valuation charts above show how its P/E and dividend yield have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.